Developing Academic Research into Clinical Therapies


06 December, 2016 - 06 December, 2016

Description: For scientists developing therapeutics - whether small molecules, biologics, or cell-based - a university lab has unique advantages as well as disadvantages compared to a research setting at a large company. Academic scientists enjoy intellectual freedom but don't have access to the same resources as their industry peers.

San Francisco, however, is fertile ground with leaders in big pharma and a supportive ecosystem for entrepreneurs. Bay Area scientists are well-positioned to commercialize their research whether they choose to partner with industry, license their technology, or launch a startup.

At UCSF we are lucky to have some of the worlds leading researchers developing therapies for unmet needs. Join us on the afternoon of Tuesday, December 6, for Developing Academic Research into Clinical Therapies, a half-day symposium featuring UCSF professors Michelle Arkin, Wendell Lim, Dean Sheppard, Brian Shoichet, and Kevan Shokat.

The symposium is open to students, postdocs, staff, and faculty.

Registration Webpage

Registration Deadline: December 5th

Contact Name: Noore Kadri

Contact E-mail: noore.kadri@qb3.org

Organization Website

Organizer: QB3, UC San Francisco (UCSF), Academic Drug Discovery Consortium (ADDC)

Event Website

Cost Range: N/A

Event Sponsors: MilliporeSigma

Address:
Genentech Hall, Byers Auditorium
San Francisco,California
United States